Concepedia

Zhengming Du

ZD

Statistics

Publications

7

Citations

426

H-Index

7

Active since

1998

Affiliations

Tris Pharma (United States)(Current)

Novartis (Switzerland)

Zhengming Du is an author at Tris Pharma (United States) specializing in medicinal chemistry, pharmacology, and natural sciences.

Publications per year

1998–2014

7

Publications

7

Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design

Paul D. Greenspan, Kirk Clark, Rubén Tommasi et al. · Journal of Medicinal Chemistry · 2001 · 136 citations · Full text

, , +15

Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2

Ronald E. Esser, Carol Berry, Zhengming Du et al. · British Journal of Pharmacology · 2005 · 123 citations · Full text

, , +13

Optimization of Halopemide for Phospholipase D2 inhibition

Lauren G. Monovich, Benjamin Mugrage, Elizabeth Quadros et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 100 citations · Full text

, , +7

A Scalable Zinc Activation Procedure Using DIBAL-H in a Reformatsky Reaction

Michael Girgis, Jessica K. Liang, Zhengming Du et al. · Organic Process Research & Development · 2009 · 24 citations

, , +12

Practical Asymmetric Hydrogenation-Based Synthesis of a Class-Selective Histone Deacetylase Inhibitor

Junli Chen, Tianqi Chen, Qiupeng Hu et al. · Organic Process Research & Development · 2014 · 17 citations

, , +14

1–5 of 7